Edoardo Migliori

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Dendritic Cells

Respiratory Syndrome Coronavirus

Respiratory Failure

Top Venues

bioRxiv : the preprint server for biology

Columbia University Columbia College

Université Libre de Bruxelles (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Columbia University Columbia College Feb 15 2018

United States

Postdoc :: Columbia Center for Translational Immunology

Education History

Université Libre de Bruxelles Nov 01 2012 - Oct 03 2017

Belgium

PHD :: Medicine

Publications

Mithil Soni, Edoardo Migliori, Jianing Fu, Amer Assal, Hei Ton Chan, Jian Pan, Prabesh Khatiwada, Rodica Ciubotariu, Michael S May, Marcus Pereira, Valeria De Giorgi, Megan Sykes, Markus Y Mapara, Pawel Muranski
The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. bioRxiv : the preprint server for biology (2023)
Mithil Soni, Edoardo Migliori, Jianing Fu, Amer Assal, Hei Ton Chan, Jian Pan, Prabesh Khatiwada, Rodica Ciubotariu, Michael S May, Marcus Pereira, Valeria De Giorgi, Megan Sykes, Markus Y Mapara, Pawel Muranski
The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. bioRxiv : the preprint server for biology (2023)
Mithil Soni, Edoardo Migliori, Jianing Fu, Amer Assal, Hei Ton Chan, Jian Pan, Prabesh Khatiwada, Rodica Ciubotariu, Michael S May, Marcus Pereira, Valeria De Giorgi, Megan Sykes, Markus Y Mapara, Pawel Muranski
The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. bioRxiv : the preprint server for biology (2023)
Cinzia Solinas, Edoardo Migliori, Pushpamali De Silva, Karen Willard-Gallo
LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer. Cancers 11 (8) (2019)